Precigen (PGEN) Interest Expenses (2012 - 2026)
Precigen's (PGEN) quarterly Interest Expenses came in at $2.9 million in Q1 2026, up 599.04% year-on-year from $416000.0 in Q1 2025, and down 4.25% on a QoQ basis from $3.0 million in Q4 2025.
Precigen (PGEN) Interest Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Interest Expenses data on file, last reported at $2.9 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 599.04% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 542.53% increase from a year earlier, with the FY2025 full-year figure at $389.9 million, down 3.5% from the prior year.
- Interest Expenses for Q1 2026 stood at $2.9 million, down from $3.0 million in the prior quarter.
- Over the last five years, Interest Expenses for PGEN reached as high as $37.3 million in Q3 2025 and fell as low as -$691000.0 in Q4 2023.
- Historically, Interest Expenses has averaged $3.9 million across 5 years, with a median of $1.1 million in 2023.
- Across the five-year window, Interest Expenses plunged 208.48% in 2023 and jumped 1866950.0% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $637000.0 in 2022, then plunged by 208.48% to -$691000.0 in 2023, then soared by 100.29% to $2000.0 in 2024, then jumped by 151750.0% to $3.0 million in 2025, then decreased by 4.25% to $2.9 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $2.9 million in Q1 2026, $3.0 million in Q4 2025, and $37.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 37.34 Mn |
| Sep 30, 2025 | 37.34 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 416,000.00 |
| Mar 31, 2025 | 416,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 8.58 Mn |
| Jun 30, 2024 | 8.58 Mn |
| Mar 31, 2024 | 572,000.00 |
| Mar 31, 2024 | 572,000.00 |
| Dec 31, 2023 | -691,000.00 |
| Dec 31, 2023 | -691,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |